bimzelx
ucb pharma s.a. - bimekizumab - psoriasis - immunosuppressiva - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
meloxicam 15 pch, tabletten 15 mg
pharmachemie b.v. - meloxicam - tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b) ; povidon (e 1201) ; siliciumdioxide (e 551) ; trinatriumcitraat 2-water (e 331), - meloxicam
meloxicam 7,5 pch, tabletten 7,5 mg
pharmachemie b.v. - meloxicam - tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; lactose 1-water ; magnesiumstearaat (e 470b) ; povidon (e 1201) ; siliciumdioxide (e 551) ; trinatriumcitraat 2-water (e 331), - meloxicam
meloxicam teva 15 mg tabl.
teva pharma belgium sa-nv - meloxicam 15 mg - tablet - 15 mg - meloxicam 15 mg - meloxicam
meloxicam teva 7.5 mg tabl.
teva pharma belgium sa-nv - meloxicam 7,5 mg - tablet - 7,5 mg - meloxicam 7.5 mg - meloxicam
duloxetine teva 30 mg, harde maagsapresistente capsules
teva b.v. swensweg 5 2031 ga haarlem - duloxetinehydrochloride 33,7 mg/stuk samenstelling overeenkomend met ; duloxetine 30 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; hyprolose (e 463) ; hypromellose (e 464) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; hypromelloseftalaat ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; maÏszetmeel ; propyleenglycol (e 1520) ; saccharose ; schellak (e 904) ; suikermaÏsbolletjes ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt, ammonia (e 527) ; briljantblauw fcf (e 133) ; hyprolose (e 463) ; hypromellose (e 464) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; hypromelloseftalaat ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; maÏszetmeel ; propyleenglycol (e 1520) ; saccharose ; schellak (e 904) ; sugar spheres ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt - duloxetine
duloxetine teva 60 mg, harde maagsapresistente capsules
teva b.v. swensweg 5 2031 ga haarlem - duloxetinehydrochloride 67,3 mg/stuk samenstelling overeenkomend met ; duloxetine 60 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; hyprolose (e 463) ; hypromellose (e 464) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; hypromelloseftalaat ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; maÏszetmeel ; propyleenglycol (e 1520) ; saccharose ; schellak (e 904) ; suikermaÏsbolletjes ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt, ammonia (e 527) ; hyprolose (e 463) ; hypromellose (e 464) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; hypromelloseftalaat ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; maÏszetmeel ; propyleenglycol (e 1520) ; saccharose ; schellak (e 904) ; sugar spheres ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt - duloxetine
duloxetine teva 30 mg harde maagsapresist. caps.
teva b.v. - duloxetinehydrochloride 33,7 mg - eq. duloxetine 30 mg - maagsapresistente capsule, hard - 30 mg - duloxetinehydrochloride 33.7 mg - duloxetine
duloxetine teva 60 mg harde maagsapresist. caps.
teva b.v. - duloxetinehydrochloride 67,3 mg - eq. duloxetine 60 mg - maagsapresistente capsule, hard - 60 mg - duloxetinehydrochloride 67.3 mg - duloxetine
colowash 1 102 mg - 398 mg tabl.
laboratoires mayoly spindler - mononatriumfosfaatmonohydraat 1102 mg; mononatriumfosfaat 398 mg - tablet - 1102 mg - 398 mg - mononatriumfosfaatmonohydraat 1102 mg; dinatriumfosfaat 398 mg - osmotically acting laxatives